As a penalty for allegedly failing to disclose the grants, the group asked NIH to take title to the patents, a rarely-used remedy available under the 1980 Bayh-Dole Act, which deals with intellectual property arising from federal government-funded research. If NIH took that action, Juxtapid — which was …
